|
Gilles Gallant joined HGS in June 2002 as Vice President Oncology Drug Development. Prior to joining HGS Dr. Gallant was Director of Clinical Oncology at Bristol-Myers Squibb Pharmaceutical Research Institute. Dr. Gallant joined Bristol-Myers Squibb in 1991 and advanced through a succession of research management positions. He played a key role in designing and directing registrational and non-registrational clinical trials of Bristol-Myers Squibb�s oncology products in the United States Europe and Canada. Dr. Gallant received his doctorate in medicinal chemistry and bachelor�s degree in pharmacy from the Universit� de Montreal in Montr�al Canada. He has co-authored numerous scientific abstracts and peer-reviewed publications in the oncology research field and is an active member of the American Society of Clinical Oncology and the American Association for Cancer Research. | 